Price Target Changes｜Ulta Beauty Boosted to $511 by Barclays; Okta Lowered to $110 by BMO Capital

Benzinga2022-08-29

Barclays boosted the price target on Ulta Beauty, Inc. from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to $407.41 in pre-market trading.
Wells Fargo boosted Prometheus Biosciences, Inc. price target from $51 to $71. Wells Fargo analyst Derek Archila maintained an Overweight rating on the stock. Prometheus Biosciences shares fell 2.2% to close at $49.40 on Friday.
BMO Capital cut Okta, Inc. price target from $125 to $110. BMO Capital analyst Keith Bachman maintained an Outperform rating on the stock. Okta shares fell 1.4% to $92.20 in pre-market trading.
Piper Sandler raised ShockWave Medical, Inc. price target from $278 to $338. Piper Sandler analyst Adam Maeder maintained an Overweight rating on the stock. ShockWave Medical shares fell 2.1% to $298.02 in pre-market trading.
Raymond James increased The Progressive Corporation price target from $135 to $140. Raymond James analyst C. Gregory Peters maintained an Outperform rating on the stock. Progressive fell 1% to close at $125.16 on Friday.
HC Wainwright & Co. increased Verona Pharma plc price target from $25 to $30. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Verona Pharma shares rose 0.6% to $10.61 in pre-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

JaiVenky
2022-08-30
JaiVenky
Smart!
tigernaut
2022-08-30
tigernaut
👍
Samuel123win
2022-08-30
Samuel123win
D
喜慶吉祥好運
2022-08-29
喜慶吉祥好運
Thanks

Leave a comment

4

162

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103399689?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-29 20:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103399689","market":"us","top_or_hot":-1,"title":"Price Target Changes｜Ulta Beauty Boosted to $511 by Barclays; Okta Lowered to $110 by BMO Capital","media":"Benzinga","content":"<html><head></head><body><ul><li>Barclays boosted the price target on <a href=\"https://laohu8.com/S/ULTA\">Ulta Beauty, Inc.</a> from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to $407.41 in pre-market trading.</li><li>Wells Fargo boosted <a href=\"https://laohu8.com/S/RXDX\">Prometheus Biosciences, Inc.</a> price target from $51 to $71. Wells Fargo analyst Derek Archila maintained an Overweight rating on the stock. Prometheus Biosciences shares fell 2.2% to close at $49.40 on Friday.</li><li>BMO Capital cut <a href=\"https://laohu8.com/S/OKTA\">Okta, Inc.</a> price target from $125 to $110. BMO Capital analyst Keith Bachman maintained an Outperform rating on the stock. Okta shares fell 1.4% to $92.20 in pre-market trading.</li><li>Piper Sandler raised <a href=\"https://laohu8.com/S/SWAV\">ShockWave Medical, Inc.</a> price target from $278 to $338. Piper Sandler analyst Adam Maeder maintained an Overweight rating on the stock. ShockWave Medical shares fell 2.1% to $298.02 in pre-market trading.</li><li>Raymond James increased <a href=\"https://laohu8.com/S/PGR\">The Progressive Corporation</a> price target from $135 to $140. Raymond James analyst C. Gregory Peters maintained an Outperform rating on the stock. Progressive fell 1% to close at $125.16 on Friday.</li><li>HC Wainwright &amp; Co. increased <a href=\"https://laohu8.com/S/VRNA\">Verona Pharma plc</a> price target from $25 to $30. HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Verona Pharma shares rose 0.6% to $10.61 in pre-market trading.</li></ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Price Target Changes｜Ulta Beauty Boosted to $511 by Barclays; Okta Lowered to $110 by BMO Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPrice Target Changes｜Ulta Beauty Boosted to $511 by Barclays; Okta Lowered to $110 by BMO Capital\n</h2>\n\n<h4 class=\"meta\">\n\n2022-08-29 20:49 北京时间&nbsp;&nbsp;&nbsp;<strong>Benzinga</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Barclays boosted the price target on Ulta Beauty, Inc. from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to $407.41 in pre-...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ULTA","symbol_name":"Ulta美容","start_time":0,"source_url":"","article_id":"1103399689","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103399689","pubTimestamp":1661777370,"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Barclays boosted the price target on Ulta Beauty, Inc. from $491 to $511. Barclays analyst Adrienne ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ULTA":"Ulta美容","RXDX":"Prometheus Biosciences, Inc."},"translate_title":"价格目标变化|巴克莱推动ULTA Beauty升至511美元；BMO Capital将Okta降至110美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RXDX":0.9,"ULTA":0.9},"content_text":"Barclays boosted the price target on Ulta Beauty, Inc. from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to $407.41 in pre-market trading.Wells Fargo boosted Prometheus Biosciences, Inc. price target from $51 to $71. Wells Fargo analyst Derek Archila maintained an Overweight rating on the stock. Prometheus Biosciences shares fell 2.2% to close at $49.40 on Friday.BMO Capital cut Okta, Inc. price target from $125 to $110. BMO Capital analyst Keith Bachman maintained an Outperform rating on the stock. Okta shares fell 1.4% to $92.20 in pre-market trading.Piper Sandler raised ShockWave Medical, Inc. price target from $278 to $338. Piper Sandler analyst Adam Maeder maintained an Overweight rating on the stock. ShockWave Medical shares fell 2.1% to $298.02 in pre-market trading.Raymond James increased The Progressive Corporation price target from $135 to $140. Raymond James analyst C. Gregory Peters maintained an Outperform rating on the stock. Progressive fell 1% to close at $125.16 on Friday.HC Wainwright & Co. increased Verona Pharma plc price target from $25 to $30. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Verona Pharma shares rose 0.6% to $10.61 in pre-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9997286886,"gmtCreate":1661816482147,"gmtModify":1676536582738,"author":{"id":"3585210617348402","authorId":"3585210617348402","name":"JaiVenky","avatar":"https://static.tigerbbs.com/097793f3135b5fb8cb3f03847d72bf1a","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3585210617348402","authorIdStr":"3585210617348402"},"htmlText":"Smart!&nbsp;","listText":"Smart!&nbsp;","text":"Smart!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9997286886","repostId":1103399689,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9997673996,"gmtCreate":1661813186118,"gmtModify":1676536581259,"author":{"id":"3567239827558758","authorId":"3567239827558758","name":"tigernaut","avatar":"https://static.tigerbbs.com/66e331c670eb88443b88c6bdb76224cf","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":1,"idStr":"3567239827558758","authorIdStr":"3567239827558758"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9997673996","repostId":1103399689,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9997666047,"gmtCreate":1661810393291,"gmtModify":1676536580233,"author":{"id":"4092554906611330","authorId":"4092554906611330","name":"Samuel123win","avatar":"https://static.tigerbbs.com/fb615bd9d23d3ee707625d59ccb06f5e","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":1,"crmLevelSwitch":0,"idStr":"4092554906611330","authorIdStr":"4092554906611330"},"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9997666047","repostId":1103399689,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9997872959,"gmtCreate":1661786295274,"gmtModify":1676536578638,"author":{"id":"4098522127473930","authorId":"4098522127473930","name":"喜慶吉祥好運","avatar":"https://community-static.tradeup.com/news/5083d220f7325633a1da1ad24c3b58d8","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4098522127473930","authorIdStr":"4098522127473930"},"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9997872959","repostId":1103399689,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":162,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103399689"}